RALLIS CHRIS A — SEC Form 4 filings
SEC reporting owner CIK 1185945. 13 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-27 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 10 filings — 25,737 shares, $184,311 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 8,346 shares @ $7.04 ($58,756) in FENNEC PHARMACEUTICALS INC., filed 2026-05-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FENNEC PHARMACEUTICALS INC. (FENC) | Director | 13 | — | 10 legs · 25,737 sh · $184,311 | 23 |
Form 4 filings — RALLIS CHRIS A
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 20,000 (derivative) @ $8.70 | EDGAR |
| 2026-05-12 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 14,344 @ $2.44 · Sale (S): 8,346 @ $7.04 · Option exercise (M): 14,344 (derivative) @ $2.44 | EDGAR |
| 2025-10-14 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 4,062 @ $1.23 · Sale (S): 1,775 @ $9.24 · Option exercise (M): 4,062 (derivative) @ $1.23 | EDGAR |
| 2025-07-07 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 2,127 @ $2.35 · Sale (S): 1,119 @ $8.71 · Option exercise (M): 2,127 (derivative) @ $2.35 | EDGAR |
| 2025-06-04 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 20,000 (derivative) @ $7.88 | EDGAR |
| 2025-04-11 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 2,173 @ $2.30 · Sale (S): 1,409 @ $4.95 · Option exercise (M): 2,173 (derivative) @ $2.30 | EDGAR |
| 2025-02-14 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 1,992 @ $2.51 · Sale (S): 1,186 @ $6.82 · Option exercise (M): 1,992 (derivative) @ $2.51 | EDGAR |
| 2024-12-02 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 10,000 @ $2.69 · Sale (S): 6,409 @ $6.14 · Option exercise (M): 10,000 (derivative) @ $2.69 | EDGAR |
| 2024-10-10 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 1,960 @ $2.55 · Sale (S): 1,406 @ $4.53 · Option exercise (M): 1,960 (derivative) @ $2.55 | EDGAR |
| 2024-08-19 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Grant/award (A): 20,000 (derivative) @ $5.58 | EDGAR |
| 2024-07-08 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Option exercise (M): 1,792 @ $2.79 · Sale (S): 1,173 @ $6.03 · Option exercise (M): 1,792 (derivative) @ $2.79 | EDGAR |
| 2024-04-15 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 800 @ $10.45 · Option exercise (M): 1,389 @ $10.45 · Option exercise (M): 1,389 (derivative) @ $3.60 | EDGAR |
| 2024-03-27 | 4 | FENNEC PHARMACEUTICALS INC. (FENC) | Sale (S): 2,114 @ $10.97 · Option exercise (M): 4,329 @ $2.31 · Option exercise (M): 4,329 (derivative) @ $2.31 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1185945 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →